Ann Marie Mauer to Doxorubicin
This is a "connection" page, showing publications Ann Marie Mauer has written about Doxorubicin.
Connection Strength
0.122
-
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. J Clin Oncol. 2019 09 10; 37(26):2338-2348.
Score: 0.041
-
Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma. Cancer Res. 1977 Oct; 37(10):3766-70.
Score: 0.036
-
Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009 May 14; 360(20):2055-65.
Score: 0.020
-
Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors. Ann Oncol. 2001 Dec; 12(12):1743-7.
Score: 0.012
-
Cell kinetics and chemotherapy in neuroblastoma. J Natl Cancer Inst. 1976 Sep; 57(3):697-9.
Score: 0.008
-
Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia. Blood. 1982 Oct; 60(4):856-63.
Score: 0.003
-
Manipulation of the mitotic cycle in the treatment of acute myelogenous leukaemia. Br J Haematol. 1976 Jan; 32(1):29-40.
Score: 0.002